Read the full feature in the May 2022 digital edition. . .
In the first quarter of 2022, China continued its push for Cosmetic Supervision and Administration Regulation (CSAR) subsidiary regulations. Additionally, the Good Manufacturing Practices (GMP) regulation and adverse reaction monitoring regulation were finalized. With these updates, a new standard also was drafted for reviewing safety assessment reports.
In addition, the ASEAN region, South Korea and China, particularly Taiwan, made significant changes to ingredient lists, and essential regulatory updates were made in Indonesia. Following is an overview.
On Jan. 7, 2022, China’s National Medical Products Administration (NMPA) published the finalized “Good Manufacturing Practices for Cosmetics,"1 which covers the basic requirements for cosmetic production quality management and all aspects of the cosmetic output and quality control.
1. Specifying the qualification and responsibility requirements for the cosmetic enterprise’s legal representative or the person in charge of quality and safety; the person in charge of the quality management department; the person in charge of the production department; and other posts related to quality and safety.
Notably, the person in charge of quality and safety shall perform their duties independently, without interference from other personnel from cosmetic enterprises, and shall not concurrently serve as the person in charge of the production department.
. . .Read the full feature in the May 2022 digital edition. . .
- ChemLinked. (2022, Jan 7). Good manufacturing practices for cosmetics. Available at: https://cosmetic.chemlinked.com/database/view/1339